• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Biogen Idec Inc. (BIIB)

    -NasdaqGS
    389.16 Up 35.91(10.17%) Jan 30, 4:00PM EST
    |After Hours : 387.50 Down 1.66 (0.43%) Jan 30, 7:33PM EST
    Add to Portfolio
    Prev Close:353.25
    Open:375.00
    Bid:N/A
    Ask:389.99 x 400
    1y Target Est:396.45
    Beta:0.83
    Earnings Date:Apr 21 - Apr 27 (Est.)
    Day's Range:372.75 - 397.00
    52wk Range:272.02 - 397.00
    Volume:4,029,832
    Avg Vol (3m):1,796,050
    Market Cap:91.64B
    P/E (ttm):36.86
    EPS (ttm):10.56
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Headlines

    » More Headlines for BIIB

    Comparison

    Symbol% ChgMkt Cap
    BIIBUp 10.17%91.64B
    PFEDown 1.82%196.90B

    Key Statistics

    Forward P/E (1 yr):19.52
    P/S (ttm):8.57
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :16.82
    Quarterly EPS Est (Mar-15) :3.89
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):1.08

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of multiple sclerosis (MS), neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback